ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization

ATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence...

Full description

Bibliographic Details
Main Authors: Jianmin Si, Chris Van den Haute, Evy Lobbestael, Shaun Martin, Sarah van Veen, Peter Vangheluwe, Veerle Baekelandt
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/5/2689
id doaj-88cd71a867f44ce29722004b71c84122
record_format Article
spelling doaj-88cd71a867f44ce29722004b71c841222021-03-08T00:01:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222689268910.3390/ijms22052689ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and ExternalizationJianmin Si0Chris Van den Haute1Evy Lobbestael2Shaun Martin3Sarah van Veen4Peter Vangheluwe5Veerle Baekelandt6Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence of impaired lysosomal export of the polyamines spermine/spermidine. Furthermore, accumulating evidence suggests the involvement of ATP13A2 in regulating the fate of α-synuclein, such as cytoplasmic accumulation and external release. However, no consensus has yet been reached on the mechanisms underlying these effects. Here, we aimed to gain more insight into how ATP13A2 is linked to α-synuclein biology in cell models with modified ATP13A2 activity. We found that loss of ATP13A2 impairs lysosomal membrane integrity and induces α-synuclein multimerization at the membrane, which is enhanced in conditions of oxidative stress or exposure to spermine. In contrast, overexpression of ATP13A2 wildtype (WT) had a protective effect on α-synuclein multimerization, which corresponded with reduced αsyn membrane association and stimulation of the ubiquitin-proteasome system. We also found that ATP13A2 promoted the secretion of α-synuclein through nanovesicles. Interestingly, the catalytically inactive ATP13A2 D508N mutant also affected polyubiquitination and externalization of α-synuclein multimers, suggesting a regulatory function independent of the ATPase and transport activity. In conclusion, our study demonstrates the impact of ATP13A2 on α-synuclein multimerization via polyamine transport dependent and independent functions.https://www.mdpi.com/1422-0067/22/5/2689ATP13A2α-synucleinα-synuclein multimerizationspermineParkinson’s disease
collection DOAJ
language English
format Article
sources DOAJ
author Jianmin Si
Chris Van den Haute
Evy Lobbestael
Shaun Martin
Sarah van Veen
Peter Vangheluwe
Veerle Baekelandt
spellingShingle Jianmin Si
Chris Van den Haute
Evy Lobbestael
Shaun Martin
Sarah van Veen
Peter Vangheluwe
Veerle Baekelandt
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
International Journal of Molecular Sciences
ATP13A2
α-synuclein
α-synuclein multimerization
spermine
Parkinson’s disease
author_facet Jianmin Si
Chris Van den Haute
Evy Lobbestael
Shaun Martin
Sarah van Veen
Peter Vangheluwe
Veerle Baekelandt
author_sort Jianmin Si
title ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
title_short ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
title_full ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
title_fullStr ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
title_full_unstemmed ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
title_sort atp13a2 regulates cellular α-synuclein multimerization, membrane association, and externalization
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-03-01
description ATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence of impaired lysosomal export of the polyamines spermine/spermidine. Furthermore, accumulating evidence suggests the involvement of ATP13A2 in regulating the fate of α-synuclein, such as cytoplasmic accumulation and external release. However, no consensus has yet been reached on the mechanisms underlying these effects. Here, we aimed to gain more insight into how ATP13A2 is linked to α-synuclein biology in cell models with modified ATP13A2 activity. We found that loss of ATP13A2 impairs lysosomal membrane integrity and induces α-synuclein multimerization at the membrane, which is enhanced in conditions of oxidative stress or exposure to spermine. In contrast, overexpression of ATP13A2 wildtype (WT) had a protective effect on α-synuclein multimerization, which corresponded with reduced αsyn membrane association and stimulation of the ubiquitin-proteasome system. We also found that ATP13A2 promoted the secretion of α-synuclein through nanovesicles. Interestingly, the catalytically inactive ATP13A2 D508N mutant also affected polyubiquitination and externalization of α-synuclein multimers, suggesting a regulatory function independent of the ATPase and transport activity. In conclusion, our study demonstrates the impact of ATP13A2 on α-synuclein multimerization via polyamine transport dependent and independent functions.
topic ATP13A2
α-synuclein
α-synuclein multimerization
spermine
Parkinson’s disease
url https://www.mdpi.com/1422-0067/22/5/2689
work_keys_str_mv AT jianminsi atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT chrisvandenhaute atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT evylobbestael atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT shaunmartin atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT sarahvanveen atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT petervangheluwe atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
AT veerlebaekelandt atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization
_version_ 1724229209100910592